{"SPADE_N_01467": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_01467", "Peptide Name": "Aurein-2.6 (Frogs, amphibians, animals)", "Source": "Litoria raniformis (Southern bell frog)", "Family": "Not found", "Gene": "Not found", "Sequence": "GLFDIAKKVIGVIGSL", "Sequence Length": 16, "UniProt Entry": ["http://www.uniprot.org/uniprot/P82393"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anticancer"], "Target Organism": "Gram-positive bacteria:Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "Cell membrane", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C77H132N18O20", "Mass": 1629.98, "PI": 8.59, "Net Charge": 1, "Hydrophobicity": 1.3, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Function": "The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.", "Tissue specificity": "Expressed by the skin dorsal glands.", "Literature": [{"Title": "The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.", "Pubmed ID": "10951191", "Reference": "Eur J Biochem. 2000 Sep;267(17)5330-5341.", "Author": "Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=10951191"}, {"Title": "Host-defence peptides of Australian anurans structure, mechanism of action and evolutionary significance.", "Pubmed ID": "15203252", "Reference": "Peptides. 2004 Jun;25(6)1035-1054.", "Author": "Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15203252"}], "Frequent Amino Acids": "GIK", "Absent Amino Acids": "CEHMNOPQRTUWY", "Basic Residues": 2, "Acidic Residues": 1, "Hydrophobic Residues": 9, "Polar Residues": 6, "Positive Residues": 2, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11592", "Similarity": 1.0, "Sequence": "KKKKPLFGLFFGLF"}, {"SPADE_ID": "SPADE_UN_23046", "Similarity": 0.8181818181818182, "Sequence": "GLFDIVKKVAG"}, {"SPADE_ID": "SPADE_N_01464", "Similarity": 0.8125, "Sequence": "GLFDIVKKVVGAIGSL"}]}}}